How it went for everyone who tried one of its treatments
Helped means they said it helped with what they took it for, which may be one symptom and not the illness. Each person counts once: someone who tried several of these treatments is split equally across those they said how it went for.
Shares are out of the 108 people who said how it went for at least one of them, each counted once, the parts rounded to whole people. 13 more tried one or credit the approach without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 39 | 36% |
| Helped | 25 | 23% |
| No change | 28 | 26% |
| Worse | 13 | 12% |
| Much worse | 3 | 3% |
How it went for everyone who tried one of its treatments
Helped means they said it helped with what they took it for, which may be one symptom and not the illness. Each person counts once: someone who tried several of these treatments is split equally across those they said how it went for.
Shares are out of the 65 people who said how it went for at least one of them, each counted once, the parts rounded to whole people. 7 more tried one or credit the approach without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 24 | 37% |
| Helped | 15 | 23% |
| No change | 15 | 23% |
| Worse | 9 | 14% |
| Much worse | 2 | 3% |
How it went for everyone who tried one of its treatments
Helped means they said it helped with what they took it for, which may be one symptom and not the illness. Each person counts once: someone who tried several of these treatments is split equally across those they said how it went for.
Shares are out of the 42 people who said how it went for at least one of them, each counted once, the parts rounded to whole people. 6 more tried one or credit the approach without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 15 | 35% |
| Helped | 10 | 24% |
| No change | 12 | 29% |
| Worse | 4 | 10% |
| Much worse | 1 | 2% |
Among the 47 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 1 | 2% |
| Near normal | 6 | 13% |
| Much better | 15 | 33% |
| Somewhat better | 15 | 32% |
| Relapsed | 9 | 20% |
| Outcome unclear | 1 | — |
Shares are rounded to add up to 100, so two equal counts can show a point apart.
Did it last?
- 11 of 47 said the benefit of a treatment in this approach wore off (4 of them among the 9 who relapsed).
- 20 of 47 say they still need to keep doing something (not always one in this approach) to stay well.
Among the 31 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 4 | 14% |
| Much better | 10 | 33% |
| Somewhat better | 12 | 40% |
| Relapsed | 4 | 13% |
| Outcome unclear | 1 | — |
Shares are rounded to add up to 100, so two equal counts can show a point apart.
Did it last?
- 4 of 31 said the benefit of a treatment in this approach wore off (1 of them among the 4 who relapsed).
- 15 of 31 say they still need to keep doing something (not always one in this approach) to stay well.
Among the 16 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 1 | 6% |
| Near normal | 2 | 13% |
| Much better | 5 | 31% |
| Somewhat better | 3 | 19% |
| Relapsed | 5 | 31% |
Did it last?
- 7 of 16 said the benefit of a treatment in this approach wore off (3 of them among the 5 who relapsed).
- 5 of 16 say they still need to keep doing something (not always one in this approach) to stay well.
Everyone · not split by condition
By how ill people were
Only the 47 who credit this approach, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Mild | 3 | 33%, few people | |
| Moderate | 9 | 11%, few people | |
| Severe | 18 | 17% | |
| Very severe | 5 | 20%, few people | |
| Not stated | 12 | 9% |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Mild | Near normal | 1 of 3 | 33% |
| Mild | Much better | 1 of 3 | 34% |
| Mild | Somewhat better | 1 of 3 | 33% |
| Moderate | Near normal | 1 of 9 | 11% |
| Moderate | Much better | 3 of 9 | 34% |
| Moderate | Somewhat better | 3 of 9 | 33% |
| Moderate | Relapsed | 2 of 9 | 22% |
| Severe | Recovered | 1 of 18 | 6% |
| Severe | Near normal | 2 of 18 | 11% |
| Severe | Much better | 7 of 18 | 39% |
| Severe | Somewhat better | 5 of 18 | 28% |
| Severe | Relapsed | 3 of 18 | 16% |
| Very severe | Near normal | 1 of 5 | 20% |
| Very severe | Much better | 3 of 5 | 60% |
| Very severe | Relapsed | 1 of 5 | 20% |
| Not stated | Near normal | 1 of 11 | 9% |
| Not stated | Much better | 1 of 11 | 9% |
| Not stated | Somewhat better | 6 of 11 | 55% |
| Not stated | Relapsed | 3 of 11 | 27% |
Everyone · not split by condition
Treatments in this approach
The bar (How it went) and the line under each name are among everyone on the site who tried it and said how it went, the same numbers as on each treatment’s own page. Recovered and Faded are among the people here who credit it. Grey numbers rest on fewer than 10 people; a faded share in red is a third or more.
20 of the 47 people
See all 47 stories-
Long COVID from bed to couch, now somewhat better, mostly housebound on clonidine, Rinvoq
Pond 55514, a US librarian, worked part time for twenty years with a mild pain-and-fatigue illness until a fifth COVID vaccine in 2022 brought hives, POTS and worse fatigue. COVID in fall 2023 cost her the job and she spent 2024 going from bed to couch.…
-
Severely ill with long COVID, now somewhat better after IV steroids and JAK inhibitors
Long COVID from early 2021 left him severely ill with seizures, depersonalisation and constant suicidal ideation; a COVID vaccine made him much worse. A suspected reinfection 18 months in cleared the inflammation and he slowly improved, and IV steroids later…
-
Long COVID with severe fatigue and brain fog, somewhat better on daratumumab
Sequoia 23892 has had long COVID for several years, with severe fatigue, brain fog, knee and back pain and orthostatic intolerance. Baricitinib, taken about 18 months, cleared their knee pain within weeks, and fludrocortisone worked better than midodrine for…
-
Bedbound with long COVID, now much better after baricitinib
A US healthcare worker infected in September 2021 had daily flu-like symptoms, crushing fatigue and several crashes a week, and was bedbound almost three months after an August 2025 crash. Baricitinib 4 mg daily from India, started November 2025, eased the…
-
Long COVID with fatigue and brain fog, much better after rapamycin and baricitinib
Hare 27693 had nearly three years of long COVID with crushing fatigue, brain fog and post-exertional malaise, mostly sitting in a recliner. LDN helped within days, amantadine and ivabradine added energy, and weekly rapamycin from November 2024 helped most:…
-
Long COVID brain fog, fatigue and PEM, now much better with baricitinib
Harbor 81164 fell ill with long COVID in March 2023 after two COVID infections, with brain fog, fatigue, PEM and tinnitus, and spent weekends on the sofa. He recovered fully by November 2024 after another COVID infection, having found 72-hour water fasts…
-
Long COVID since 2021; baricitinib helped neurological symptoms then a bad relapse
Had been ill with long COVID since 2021 and had lost years to it. In 2026 the JAK inhibitor baricitinib improved their neurological symptoms and they thought they had found the answer, but two to three months later they worsened badly and it was awful. By…
-
Severe long COVID pain at 10/10, somewhat better with a JAK inhibitor and Lyme treatments
Living with long COVID and multiple autoimmune issues, they described severe pain at 10/10 with scarring over quickly. Cyclosporine, prednisone and many other medications failed them, and a medication at 3 mg for over a year did nothing. Only a JAK inhibitor…
-
Bedridden with long COVID, now nearly back to normal on maraviroc and Rinvoq
A second COVID infection in July 2024 led to PEM, fatigue, aches, neuropathy and double vision a month later, plus POTS-like symptoms; they became bedridden with pain, malaise and fatigue and lost weight from 220 to 162 lbs. A Pfizer booster left them worse…
-
Housebound for six months with long COVID, now much better with LDN and baricitinib
A man who caught COVID in May 2022 developed ME/CFS-type long COVID and spent six months housebound after pushing through a move for a PhD program. Pacing and treatments including low-dose naltrexone, antihistamines and valacyclovir helped, with LDN largely…
-
Moderate/severe ME/CFS: Rinvoq eased symptoms, but they returned after infection
Beech 27352 has moderate/severe ME/CFS, POTS and Crohn's disease. Rinvoq, prescribed for Crohn's, eased fatigue, brain fog, vertigo, headache and sleep within two weeks, but a minor infection forced her to stop and all symptoms returned. After restarting,…
-
Long COVID brain fog and crashes: baricitinib and Pemgarda helped, then symptoms returned
A doctor who has had long COVID for nearly six years. Baricitinib 4 mg, started around August 2024, lifted brain fog within hours and left them at least 50% better, though crashes and chest pain continued. A Pemgarda infusion three months before their last…
-
Long COVID sometimes bedbound, much better after antivirals and apixaban
A Spanish man fell ill after a second AstraZeneca dose in December 2021 and worsened for two years, sometimes bedbound for days. Apixaban with aspirin and high-dose enzymes, then antivirals, cleared his breathlessness, nausea and poor sleep; he credited the…
-
Almost completely bed bound with ME/CFS, now much better on a JAK inhibitor and ursodiol
A resident physician who developed post-viral dysautonomia after a 2021 upper respiratory infection, later meeting criteria for ME/CFS and POTS. Plasmapheresis and SCIG helped, but stopping PLEX in 2022 triggered a crash and a year-long decline to almost…
-
Long COVID with tremor and insomnia, now nearly back to normal on LDN and rapamycin
He developed long COVID after a COVID infection in June 2022, with neck weakness, a Parkinson-like tremor, severe insomnia, high heart rate, brain fog and eye changes. LDN, Rapamycin and baricitinib each helped, but he was not fully cured. He had COVID twice…
-
Long COVID with POTS and activity crashes, much better on baricitinib
A year into long COVID, with POTS and crashes from small amounts of activity, they had tried many treatments with little effect. Baricitinib, started after a cytokine panel showed around 30 abnormal factors, brought small gains at week 3-4 and a clear…
-
Long COVID with POTS and PEM, wheelchair for outings, somewhat better on Rinvoq
A former long-distance runner who fell ill with a bad COVID case in October 2020 developed POTS, neuropathy, myopathy, headache, breathlessness and PEM, needing a power wheelchair for outings. IVIG, steroids, antihistamines, plaquenil and Humira (allergic…
-
Very frail with ME/CFS, now somewhat better after stopping baricitinib
A Reddit user with ME/CFS described themselves as very frail and prone to side effects. Valacyclovir with celecoxib helped a lot for two months but the benefit stopped when they stopped, and it made their meninges hot, so they quit. Baricitinib made them…
-
dr. Arf on Phoenix Rising
dr. Arf had ME/CFS for years, taking antibiotics under Professor Meirleir without improvement. Five weeks of the Coimbra high-dose vitamin D protocol in 2017 left them bedbound, and they described themselves as very severe, at about 2 steps a day. Filgotinib…
-
Long COVID with fatigue and brain fog, now much better after treatment and yoga
They had long COVID for about three and a half years, with fatigue and brain fog the worst of it. A six-month course of treatment brought improvements that came on gradually over the year and were still holding six months after stopping; they put themselves…
The newest 20 people who credit JAK inhibitors.
20 of the 31 people
See all 31 stories-
Long COVID from bed to couch, now somewhat better, mostly housebound on clonidine, Rinvoq
Pond 55514, a US librarian, worked part time for twenty years with a mild pain-and-fatigue illness until a fifth COVID vaccine in 2022 brought hives, POTS and worse fatigue. COVID in fall 2023 cost her the job and she spent 2024 going from bed to couch.…
-
Severely ill with long COVID, now somewhat better after IV steroids and JAK inhibitors
Long COVID from early 2021 left him severely ill with seizures, depersonalisation and constant suicidal ideation; a COVID vaccine made him much worse. A suspected reinfection 18 months in cleared the inflammation and he slowly improved, and IV steroids later…
-
Long COVID with severe fatigue and brain fog, somewhat better on daratumumab
Sequoia 23892 has had long COVID for several years, with severe fatigue, brain fog, knee and back pain and orthostatic intolerance. Baricitinib, taken about 18 months, cleared their knee pain within weeks, and fludrocortisone worked better than midodrine for…
-
Bedbound with long COVID, now much better after baricitinib
A US healthcare worker infected in September 2021 had daily flu-like symptoms, crushing fatigue and several crashes a week, and was bedbound almost three months after an August 2025 crash. Baricitinib 4 mg daily from India, started November 2025, eased the…
-
Long COVID with fatigue and brain fog, much better after rapamycin and baricitinib
Hare 27693 had nearly three years of long COVID with crushing fatigue, brain fog and post-exertional malaise, mostly sitting in a recliner. LDN helped within days, amantadine and ivabradine added energy, and weekly rapamycin from November 2024 helped most:…
-
Long COVID brain fog, fatigue and PEM, now much better with baricitinib
Harbor 81164 fell ill with long COVID in March 2023 after two COVID infections, with brain fog, fatigue, PEM and tinnitus, and spent weekends on the sofa. He recovered fully by November 2024 after another COVID infection, having found 72-hour water fasts…
-
Long COVID since 2021; baricitinib helped neurological symptoms then a bad relapse
Had been ill with long COVID since 2021 and had lost years to it. In 2026 the JAK inhibitor baricitinib improved their neurological symptoms and they thought they had found the answer, but two to three months later they worsened badly and it was awful. By…
-
Severe long COVID pain at 10/10, somewhat better with a JAK inhibitor and Lyme treatments
Living with long COVID and multiple autoimmune issues, they described severe pain at 10/10 with scarring over quickly. Cyclosporine, prednisone and many other medications failed them, and a medication at 3 mg for over a year did nothing. Only a JAK inhibitor…
-
Bedridden with long COVID, now nearly back to normal on maraviroc and Rinvoq
A second COVID infection in July 2024 led to PEM, fatigue, aches, neuropathy and double vision a month later, plus POTS-like symptoms; they became bedridden with pain, malaise and fatigue and lost weight from 220 to 162 lbs. A Pfizer booster left them worse…
-
Housebound for six months with long COVID, now much better with LDN and baricitinib
A man who caught COVID in May 2022 developed ME/CFS-type long COVID and spent six months housebound after pushing through a move for a PhD program. Pacing and treatments including low-dose naltrexone, antihistamines and valacyclovir helped, with LDN largely…
-
Long COVID brain fog and crashes: baricitinib and Pemgarda helped, then symptoms returned
A doctor who has had long COVID for nearly six years. Baricitinib 4 mg, started around August 2024, lifted brain fog within hours and left them at least 50% better, though crashes and chest pain continued. A Pemgarda infusion three months before their last…
-
Long COVID sometimes bedbound, much better after antivirals and apixaban
A Spanish man fell ill after a second AstraZeneca dose in December 2021 and worsened for two years, sometimes bedbound for days. Apixaban with aspirin and high-dose enzymes, then antivirals, cleared his breathlessness, nausea and poor sleep; he credited the…
-
Long COVID with tremor and insomnia, now nearly back to normal on LDN and rapamycin
He developed long COVID after a COVID infection in June 2022, with neck weakness, a Parkinson-like tremor, severe insomnia, high heart rate, brain fog and eye changes. LDN, Rapamycin and baricitinib each helped, but he was not fully cured. He had COVID twice…
-
Long COVID with POTS and activity crashes, much better on baricitinib
A year into long COVID, with POTS and crashes from small amounts of activity, they had tried many treatments with little effect. Baricitinib, started after a cytokine panel showed around 30 abnormal factors, brought small gains at week 3-4 and a clear…
-
Long COVID with POTS and PEM, wheelchair for outings, somewhat better on Rinvoq
A former long-distance runner who fell ill with a bad COVID case in October 2020 developed POTS, neuropathy, myopathy, headache, breathlessness and PEM, needing a power wheelchair for outings. IVIG, steroids, antihistamines, plaquenil and Humira (allergic…
-
Long COVID with fatigue and brain fog, now much better after treatment and yoga
They had long COVID for about three and a half years, with fatigue and brain fog the worst of it. A six-month course of treatment brought improvements that came on gradually over the year and were still holding six months after stopping; they put themselves…
-
Long COVID brain fog and derealization, somewhat better with low-dose naltrexone
Posted in a long COVID forum about persistent brain fog, derealization and some anxiety. Low-dose naltrexone, titrated from 0.5 mg upwards, brought noticeable improvement after about three to four months, though fog remained on bad days. A baricitinib trial…
-
Close to bedbound with long COVID brain fog, now near normal after baricitinib
After COVID in 2025 they developed dementia-level brain fog, a resting heart rate near 115, adrenaline rushes, insomnia and anhedonia. By early 2026 they were close to bed bound, about 20% of normal. Baricitinib, bought from India after a $1,500-2,000…
-
Bedbound with long COVID, now much better after baricitinib and antivirals
Creek 60804 developed long COVID after a fourth infection, with symptoms since October 2022, and became bedbound with brain fog, POTS, PEM and fatigue. A stellate ganglion block helped temporarily, and antivirals helped too; baricitinib, bought cheaply…
-
Long COVID with pain, fatigue and brain fog, somewhat better on baricitinib
They have had long COVID since March 2022 with joint and back pain, muscle pain, fatigue, brain fog, PEM and mild POTS symptoms. Low-dose naltrexone helped within an hour in January 2025 but wore off after a week; baricitinib, started in May 2025, they say…
The newest 20 people with long COVID who credit JAK inhibitors.
All 16 people
-
Moderate/severe ME/CFS: Rinvoq eased symptoms, but they returned after infection
Beech 27352 has moderate/severe ME/CFS, POTS and Crohn's disease. Rinvoq, prescribed for Crohn's, eased fatigue, brain fog, vertigo, headache and sleep within two weeks, but a minor infection forced her to stop and all symptoms returned. After restarting,…
-
Almost completely bed bound with ME/CFS, now much better on a JAK inhibitor and ursodiol
A resident physician who developed post-viral dysautonomia after a 2021 upper respiratory infection, later meeting criteria for ME/CFS and POTS. Plasmapheresis and SCIG helped, but stopping PLEX in 2022 triggered a crash and a year-long decline to almost…
-
Very frail with ME/CFS, now somewhat better after stopping baricitinib
A Reddit user with ME/CFS described themselves as very frail and prone to side effects. Valacyclovir with celecoxib helped a lot for two months but the benefit stopped when they stopped, and it made their meninges hot, so they quit. Baricitinib made them…
-
dr. Arf on Phoenix Rising
dr. Arf had ME/CFS for years, taking antibiotics under Professor Meirleir without improvement. Five weeks of the Coimbra high-dose vitamin D protocol in 2017 left them bedbound, and they described themselves as very severe, at about 2 steps a day. Filgotinib…
-
ME/CFS symptoms cleared for four months on Rinvoq, then a crash left them bedbound
Kestrel 24840, who also has Crohn's disease and spondyloarthritis, dates CFS onset to February 2023. Rinvoq, taken for Crohn's, cleared all CFS symptoms for four months and allowed sport, but the benefit stopped and a crash left them bedbound for two weeks.…
-
20 years of ME/CFS with pain and poor sleep, now much better on Rinvoq and LDN
A Reddit user with 20 years of CFS, pain, poor sleep, gut problems and MCAS got their best summer since onset in 2020 on LDN, an antihistamine and eight weeks of rest. A single dose of Dupixent in autumn 2025 worsened their baseline. Three days after…
-
Mbajda on Phoenix Rising
Mbajda fell ill in college over 25 years ago, partly recovered, then had two further blows, the worst after a toxic exposure that left him unable to get off the floor for months. Prolonged water and dry fasts did nothing. After a year on tofacitinib and then…
-
Nearly bedbound with ME/CFS for a year, now much better after prednisone and rest
They became ill with ME/CFS after long COVID in early 2022 and were nearly bedbound for about 12 months before improving to mild. Infections in early 2025 and rheumatoid arthritis dropped them to moderate; low-dose prednisone then brought near recovery, and…
-
Filgotinib (JAK1 inhibitor) - future of CFS/ME treatment
Edgeworth was ill for about three years with suspected ME/CFS, mostly housebound at worst and able to sit upright only 20 minutes at a time. In early 2023 a three-day course of filgotinib, a JAK1 inhibitor, lifted the illness within days; since then he has…
-
Three clinical trials for Long COVID are testing JAK inhibitors (Jen)
Jen had severe myalgic encephalomyelitis for nearly two decades after falling ill in Central America in 2006, and had tried more than a hundred medications. She took upadacitinib (Rinvoq) from December 2023 for 66 days, stopping due to profound weakness,…
-
JAK1 inhibitor Rinvoq quickly returns severely ill ME/CFS patient to health - Parts I and II
Sushi took Rinvoq for two months and reports very significant benefits, including normalised orthostatic intolerance, temperature regulation, appetite and sleep, plus a bit more stamina. They felt much worse while taking it and for a few weeks after…
-
Progressively disabled by ME/CFS over 16 years, improved on Xeljanz then relapsed
ME/CFS had made them progressively more disabled over 16 years, with POTS, hypothyroidism, refractory migraine and overactive bladder. Xeljanz improved their insomnia, exhaustion and bladder within a week, but the benefit faded after about 6.5 months, and a…
-
Slushiefan on Phoenix Rising
Slushiefan had CFS for about 40 years, working full time in stretches before losing jobs to the illness and going back on disability, a step above bedridden. Methylene blue gave an immediate, lasting but modest energy and brain-fog boost; Rinvoq eased pain…
-
From Severe ME/CFS to Healed: Jen's Remarkable Rinvoq ME/CFS Recovery Story
Jen was bedbound about 90% of the time for 18 years after a flu-like infection in 2006, with post-exertional malaise and dysautonomia. She took Rinvoq 15 mg daily for two months, felt worse on it, and stopped when her white cell count fell dangerously low.…
-
Treatment with KDM Miraculous So Far, Need Help with Dysbiosis Though
sam.d had PEM flares lasting about 20 days after minimal exertion, plus severe IBS and constipation, and by 2017 was near bed-bound. KDM's protocol, including Gammanorm injections, brought a big improvement in 2018, but he regressed between 2019 and 2022.…
-
impossible on Phoenix Rising
impossible fell ill at 13 after dental amalgams and spent years as a hard-case ME/CFS patient with severe gut infections, brain fog and later MCAS. Mould avoidance and cholestyramine brought a big improvement in 2014, clearing his orthostatic intolerance,…